A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

Clinical trial NCT03004534 · COMPLETED

Trial details

NCT number: NCT03004534
Sponsor: Translational Research in Oncology
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Female

Start date: 2017-09-05
Primary completion: 2019-02-14
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.